Administrative Guidance against 日本政府（厚生労働省）
Action summary
- Company
- 日本政府（厚生労働省）Japanese onlyOriginal: 日本政府（厚生労働省）
- Governing law
- Specified Commercial Transactions Act特定商取引法
- Action type
- Administrative Guidance行政指導
- Action date
- July 18, 2018
- Issuing authority
- Ministry of Health, Labour and Welfare厚生労働省
Violation
With this signing exchange, the scope of pharmaceuticals subject to GMP mutual recognition under the agreement has been expanded to include active pharmaceutical ingredients (APIs), sterile pharmaceuticals, vaccines, and other biological medicines, covering most pharmaceuticals.
Show original Japanese text
この署名交換をもって、協定によるＧＭＰ相互承認の対象医薬品が、原薬（有効成分）、無菌医薬品、ワクチンなどの生物学的医薬品にも拡大し、ほとんどの医薬品をカバーすることになりました。
Source
Original Ministry of Health, Labour and Welfare announcement (in Japanese)The original Japanese disclosure is the authoritative record.
Watch this company
Get an email when 日本政府（厚生労働省） has new enforcement actions or registry changes (representative, address, business status). Sign-in is via a one-time email link — no password.
Language
日本語版を見る (Japanese)About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.